Cargando…

Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants

OBJECTIVES: The aim of this study is to present the clinical, oncological, and functional results of locally aggressive benign bone tumors treated with extended intralesional curettage without the use of adjuvant in a tertiary orthopedic oncology center. METHOD: A total of 172 patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yenigül, Ali Erkan, Sofulu, Ömer, Erol, Bülent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036382/
https://www.ncbi.nlm.nih.gov/pubmed/35481245
http://dx.doi.org/10.1177/20503121221094199
_version_ 1784693512360427520
author Yenigül, Ali Erkan
Sofulu, Ömer
Erol, Bülent
author_facet Yenigül, Ali Erkan
Sofulu, Ömer
Erol, Bülent
author_sort Yenigül, Ali Erkan
collection PubMed
description OBJECTIVES: The aim of this study is to present the clinical, oncological, and functional results of locally aggressive benign bone tumors treated with extended intralesional curettage without the use of adjuvant in a tertiary orthopedic oncology center. METHOD: A total of 172 patients treated with surgical curettage and high-speed burrs for the diagnosis of aneurysmal bone cyst, giant cell tumor, osteoblastoma, chondroblastoma, and chondromyxoid fibroma were included in the study. Demographic, radiological, and clinical data of the patients were analyzed. RESULTS: One-hundred seventy two patients (101 (59%) female and 71 (41%) male) with a mean age of 23 years (6–84). The mean follow-up period was 48 months (18–108). In the study, a total of 8 (4.6%) patients had postoperative complications, 17 (9.9%) patients had recurrence in the postoperative period. Diameter greater than 5 cm was found to be a risk factor for recurrence (p < 0.004). The probability of developing complications was found to be significantly higher in patients with recurrence (p < 0.001). There was no significant relationship between recurrence and age, tumor type, and tumor stage. CONCLUSION: Successful treatment results can be obtained with extended surgical curettage, high-speed burr, and cauterization without the use of chemical adjuvants in locally aggressive bone tumors.
format Online
Article
Text
id pubmed-9036382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-90363822022-04-26 Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants Yenigül, Ali Erkan Sofulu, Ömer Erol, Bülent SAGE Open Med Original Research Article OBJECTIVES: The aim of this study is to present the clinical, oncological, and functional results of locally aggressive benign bone tumors treated with extended intralesional curettage without the use of adjuvant in a tertiary orthopedic oncology center. METHOD: A total of 172 patients treated with surgical curettage and high-speed burrs for the diagnosis of aneurysmal bone cyst, giant cell tumor, osteoblastoma, chondroblastoma, and chondromyxoid fibroma were included in the study. Demographic, radiological, and clinical data of the patients were analyzed. RESULTS: One-hundred seventy two patients (101 (59%) female and 71 (41%) male) with a mean age of 23 years (6–84). The mean follow-up period was 48 months (18–108). In the study, a total of 8 (4.6%) patients had postoperative complications, 17 (9.9%) patients had recurrence in the postoperative period. Diameter greater than 5 cm was found to be a risk factor for recurrence (p < 0.004). The probability of developing complications was found to be significantly higher in patients with recurrence (p < 0.001). There was no significant relationship between recurrence and age, tumor type, and tumor stage. CONCLUSION: Successful treatment results can be obtained with extended surgical curettage, high-speed burr, and cauterization without the use of chemical adjuvants in locally aggressive bone tumors. SAGE Publications 2022-04-22 /pmc/articles/PMC9036382/ /pubmed/35481245 http://dx.doi.org/10.1177/20503121221094199 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Yenigül, Ali Erkan
Sofulu, Ömer
Erol, Bülent
Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
title Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
title_full Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
title_fullStr Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
title_full_unstemmed Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
title_short Treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
title_sort treatment of locally aggressive benign bone tumors by means of extended intralesional curettage without chemical adjuvants
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036382/
https://www.ncbi.nlm.nih.gov/pubmed/35481245
http://dx.doi.org/10.1177/20503121221094199
work_keys_str_mv AT yenigulalierkan treatmentoflocallyaggressivebenignbonetumorsbymeansofextendedintralesionalcurettagewithoutchemicaladjuvants
AT sofuluomer treatmentoflocallyaggressivebenignbonetumorsbymeansofextendedintralesionalcurettagewithoutchemicaladjuvants
AT erolbulent treatmentoflocallyaggressivebenignbonetumorsbymeansofextendedintralesionalcurettagewithoutchemicaladjuvants